Pharmacokinetics, safety, and tolerability of paliperidone palmitate 3-month formulation in patients with schizophrenia: A phase 1, single-dose, randomized, open-label study - Ravenstijn, P; Remmerie, B; Savitz, A (J Clin Pharmacol, 2016)
et al.